Asia Insurance Post
  • Home
  • Articles
  • Blog
  • Data
  • Facts
  • Editorial
  • Interviews
Select Page

Maharasthra Covid cases up; new Omicron subvariants BQ.1, XBB reported from state

by AIP Online Bureau | Oct 18, 2022 | Health, Indian News, Non-Life, Pandemic, Policy

On October 17, India detected its first case of Omicron’s BQ.1 subvariant in a sample of a patient from Pune. The BQ.1 is a descendant of BA.5, which is behind the 60 per cent Covid cases in the United States (US), as per reports Mumbai: A meeting between Union...

SC asks Rajasthan to pay compensation to children orphaned by Covid within 2 wks

by AIP Online Bureau | Oct 14, 2022 | Health, Indian News, Pandemic

“In so far as pending applications for compensation to orphans are concerned, we direct the state to make the payment to remaining applicants whose parents have died due to Covid within two weeks,” the bench said. New Delhi: The Supreme Court on Friday...

Covid helpline received 6.62 lakh calls related to viral disease between Sept 2021 and August this year

by AIP Online Bureau | Sep 26, 2022 | Data, Eco/Invest/Demography, Health, Non-Life, Technology

The helpline was also used for helping citizens with Co-WIN registration and vaccine appointment booking since December 2020 New Delhi: More than 6.62 lakh calls were made to the government’s COVID-19 helpline number — 1075 — with queries related to...

Sense of an ending: Scientists say worst of Covid could be over

by AIP Online Bureau | Sep 23, 2022 | Health, International News, Non-Life, Pandemic

”We have spent two-and-a-half years in a long, dark tunnel, and we are just beginning to glimpse the light at the end of that tunnel,” WHO Director General Tedros Adhanom Ghebreyesus Tedros said on the sidelines of the UN General Assembly on Thursday. Globally,...

DCGI nod to Bharat Biotech’s intranasal Covid vaccine for restricted emergency use

by AIP Online Bureau | Sep 7, 2022 | Health, Indian News, Pandemic

”Big Boost to India’s Fight Against COVID-19! Bharat Biotech’s ChAd36-SARS-CoV-S COVID-19 (Chimpanzee Adenovirus Vectored) recombinant nasal vaccine approved by @CDSCO_INDIA_INF for primary immunization against COVID-19 in 18+ age group for...
« Older Entries
Next Entries »

Recent Posts

  • No proposal under consideration on merger of PSU banks: MoS Finance
  • Indian drugmakers flood market with cheaper versions of Novo’s Ozempic, Wegovy
  • Ayushman Bharat crosses 11.69 crore hospital admissions, 6.74 crore in private hospitals: Govt
  • Indian Non-Life Insurance Industry:On a growth trajectory
  • 2 pilots killed as Air Canada Express plane hits ground vehicle at New York’s LaGuardia airport, multiple injuries reported

Categories

  • Articles
  • Banking & Bancassurance
  • Blog
  • Breaking News!
  • Briefs
  • Climate, Environment, Renewable Energy
  • Data
  • Disaster & Management
  • Eco/Invest/Demography
  • Editorial
  • Events
  • Facts
  • Features
  • Health
  • Indian News
  • Intermediaries
  • International News
  • Interviews
  • Life
  • Main Menu
  • Non-Life
  • Pandemic
  • Pension & Social Security
  • Policy
  • Regulation
  • Reinsurance
  • Risk Management
  • Simple
  • Technology
  • Trends, Facts
  • Uncategorized
  • Wealth Management/ Philanthropy
  • Workplace/Employee Benefits
  • Home
  • Articles
  • Blog
  • Data
  • Facts
  • Editorial
  • Interviews
  • Eco/Invest/Demography
  • Indian News
  • International News
  • Health
  • Non-Life
  • Pandemic
  • Technology
  • Risk Management
  • Reinsurance
  • Banking & Bancassurance
  • Wealth Management/ Philanthropy